Humacyte, Inc. logo

Humacyte, Inc.

NASDAQ:HUMA

Overview | Financials
Company Name Humacyte, Inc.
Symbol HUMA
Currency USD
Price 4.68
Market Cap 602,166,240
Dividend Yield 0%
52-week-range 2.48 - 9.97
Industry Biotechnology
Sector Healthcare
CEO Dr. Laura E. Niklason M.D., Ph.D.
Website https://www.humacyte.com

An error occurred while fetching data.

About Humacyte, Inc.

Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs). Its

Related Stocks

Orthofix Medical Inc. logo

Orthofix Medical Inc.

OFIX

17.13 USD

Quantum-Si incorporated logo

Quantum-Si incorporated

QSI

2.64 USD

Collegium Pharmaceutical, Inc. logo

Collegium Pharmaceutical, Inc.

COLL

33.34 USD

BioLife Solutions, Inc. logo

BioLife Solutions, Inc.

BLFS

27.69 USD

Surmodics, Inc. logo

Surmodics, Inc.

SRDX

39 USD

Vaxxinity, Inc. logo

Vaxxinity, Inc.

VAXX

0.001 USD

Bioventus Inc. logo

Bioventus Inc.

BVS

9.58 USD

Financials

Numbers are in millions USD

Numbers are in millions USD